Common Stock, Shares, Outstanding of Protagonist Therapeutics, Inc from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Protagonist Therapeutics, Inc quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Protagonist Therapeutics, Inc Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 62,577,897, a 2.5% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Protagonist Therapeutics, Inc Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 62,577,897 +1,542,758 +2.5% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 62,447,102 +2,925,199 +4.9% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 62,107,572 +3,345,509 +5.7% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 61,928,760 +3,327,973 +5.7% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 61,035,139 +3,326,526 +5.8% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 59,521,903 +1,874,427 +3.3% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 58,762,063 +1,267,878 +2.2% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 58,600,787 +7,160,284 +14% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 57,708,613 +8,369,361 +17% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 57,647,476 +8,449,065 +17% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 57,494,185 +8,810,254 +18% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 51,440,503 +2,888,401 +5.9% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 49,339,252 +1,500,922 +3.1% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 49,198,411 +1,526,757 +3.2% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 48,683,931 +1,158,371 +2.4% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 48,552,102 +4,612,856 +10% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 47,838,330 +4,092,865 +9.4% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 47,671,654 +10,356,781 +28% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 47,525,560 +10,723,421 +29% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 43,939,246 +16,504,541 +60% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 43,745,465 +16,527,816 +61% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 37,314,873 +10,108,426 +37% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 36,802,139 +11,834,536 +47% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 27,434,705 +4,042,171 +17% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 27,217,649 +4,030,430 +17% 31 Dec 2019 10-K 10 Mar 2021 2020 FY
Q3 2019 27,206,447 +3,068,345 +13% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 24,967,603 +3,750,109 +18% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 23,392,534 +2,228,944 +11% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 23,187,219 +2,098,913 +10% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q3 2018 24,138,102 +7,193,999 +42% 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 21,217,494 +4,318,233 +26% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 21,163,590 +4,328,943 +26% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 21,088,306 +4,366,026 +26% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q3 2017 16,944,103 +229,650 +1.4% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 16,899,261 +16,515,351 +4302% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 16,834,647 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 16,722,280 +16,449,871 +6039% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q3 2016 16,714,453 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 383,910 30 Jun 2016 10-Q 15 Sep 2016 2016 Q2
Q4 2015 272,409 31 Dec 2015 10-K 07 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.